Abstract-H11 kinase/Hsp22 (H11K) is a chaperone promoting cardiac cell growth and survival through the activation of Akt, a downstream effector of phosphatidylinositol 3-kinase (PI3K). In this study, we tested whether H11K-induced activation of the PI3K/Akt pathway is mediated by the bone morphogenetic protein (BMP) signaling, both in a transgenic mouse model with cardiac-specific overexpression of H11K and in isolated cardiac myocytes. Microarrays in hearts from transgenic compared to wild-type mice showed an upregulation of the BMP receptors Alk3 and BMPR-II, and of their ligand BMP4 (PϽ0.01 versus wild type). Activation of the BMP pathway in transgenic mice was confirmed by increased phosphorylation of the "canonical" BMP effectors Smad 1/5/8 (PϽ0.01 versus wild type). In isolated myocytes, adenovirus-mediated overexpression of H11K was accompanied by a significant (PϽ0.01) increase in PI3K activity, phospho-Akt, Smad 1/5/8 phosphorylation and [ 3 H]phenylalanine incorporation, and by a 70% reduction in H 2 O 2 -mediated apoptosis. All these effects were abolished by the BMP antagonist noggin. In presence of BMP4, Smad 1/5/8 phosphorylation was enhanced by 5-fold on H11K overexpression but decreased by 3-fold on H11K knockdown (PϽ0.01 versus control), showing that H11K potentiates the BMP signaling. In pull-down experiments, H11K increased both the association of Alk3 and BMPR-II together, and their interaction with the transforming growth factor--activated kinase (TAK)1, a "noncanonical" mediator of the BMP receptor signaling. TAK1 inhibition prevented H11K-mediated activation of Akt. Therefore, potentiation of the BMP receptor by H11K promotes an activation of the PI3K/Akt pathway mediated by TAK1, which dictates the physiological effects of H11K on cardiac cell growth and survival. Key Words: Akt Ⅲ bone morphogenetic protein Ⅲ heat shock protein Ⅲ phosphatidylinositol 3-kinase H 11 kinase/Hsp22 (H11K), which belongs to the crystallin family of heat shock proteins, is mainly expressed in heart and skeletal muscle. 1 An increase in H11K expression was found in a canine model of left ventricular hypertrophy, 2 in swine models of acute and repetitive myocardial ischemia, 3,4 and in patients with ischemic heart disease. 4 We generated a transgenic (TG) mouse with cardiac-specific overexpression of H11K to a level (3-to 5-fold) reproducing the increased expression found in the animal models and in patients. This TG model shows that H11K stimulates cardiac cell growth 2 and promotes cardiac cell survival to an extent reproducing the protection conferred by ischemic preconditioning. 5 We showed previously that these protective effects of H11K correlate with the activation of Akt, and of its downstream survival pathway. 2,5,6 The main activator of Akt is the phosphatidylinositol 3-kinase (PI3K), which phosphorylates Akt via the phosphatidylinositol-dependent kinase (PDK)1, and which is itself under the control of multiple growth factor receptors. 7 Our goal was to elucidate the mechanisms leading to H11K-mediated ...